Minority, Low Socioeconomic Status Women Have Less Access to Digital Breast Tomosynthesis Screening

Women of minority race and low socioeconomic status have lower access to digital breast tomosynthesis (DBT) screening, which may contribute to persisting disparities in breast cancer screening, according to a study. DBT, or three-dimensional mammography,...

Journal Reading List

Multiple Myeloma Knowledge Hub

video

Dr. Hari Discusses Upfront Autologous Transplantation for Multiple Myeloma

Parameswaran Hari, MD, Chief of Hematology/Oncology at the Medical College of Wisconsin, spoke with DocWire News about how new therapeutic agents are changing the...

Double ASCT in MM Does Not Increase Survival Compared to Single ASCT

Patients with multiple myeloma (MM) who underwent double autologous stem cell transplantation (ASCT) did not have better overall survival (OS) and progression-free survival (PFS)...
IV bag

POLLUX and CASTOR: Daratumumab Combinations for MM Prolong MRD-Negativity

Therapeutic regimens for multiple myeloma (MM) that use a combination of the anti-CD38 monoclonal antibody daratumumab induce higher rates of sustained minimal residual disease...
Benzodiazepine Use On The Rise to Treat Pain

Real-World Efficacy of All-Oral Triplet Regimen for Myeloma

In an analysis of real-world data, the all-oral triplet regimen of ixazomib, lenalidomide, and dexamethasone (IRD) for the treatment of multiple myeloma (MM) was...
Prognostic Value of Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced Cardiotoxicity

Low One-Year Adherence to Lenalidomide in Multiple Myeloma

Real-world data from a single institution showed concerningly low levels of long-term adherence to lenalidomide therapy for multiple myeloma (MM). For this study, researchers sought...
video

Benefits of Antibody Drug Conjugates for Multiple Myeloma, with Dr. Chakraborty

DocWire News spoke with Raj Chakraborty, MD, assistant professor of medicine at Columbia University Irving Medical Center, Division of Hematology/Oncology, on the benefits of...

International Data on Multiple Myeloma Link Socioeconomic Status to Mortality

Across the globe, socioeconomic status (SES) was shown to be a prognosis factor for overall survival (OS) among patients with multiple myeloma (MM), according...
Cancer Surpassing Heart Disease as Leading Cause of U.S. Deaths

Myeloma Treatment Improvements Are Less Beneficial to High-Risk Patients

An analysis of patients with multiple myeloma (MM) who underwent autologous hematopoietic cell transplant (AHCT) showed that overall improvement in outcomes over time primarily...
Advertisement
Advertisement